Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow—and how blocking them could help the body fight back.

Jason Junkins, M.D., and his wife, Angela For local urgent care physician Jason Junkins, M.D., prostate cancer was not on his ...

A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas ...

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

ALBUQUERQUE, N.M. – New technology at Presbyterian Hospital is giving men one more way to face a cancer diagnosis. The ...

We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...

To close out Men’s Health Month, the Cancer Connections team sat down with Dr. William Dahut, the American Cancer Society’s ...

Diffusion basis spectrum imaging combined with AI enhances diagnostic accuracy for prostate cancer A study published in the ...

Hormone therapy for prostate cancer is aimed at reducing or eliminating the amount of testosterone in your body to slow or stop prostate cancer cells from growing and multiplying. Hormone therapy ...

Background: The costs of treating localized, Gleason score 9 and 10 prostate cancer remain poorly described, especially when the particularly aggressive nature of the disease often requires a ...

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...